The FDA has revised the current QSR and released the final rule for Quality Management System Regulation (QMSR). The design goal of QMSR is to promote consistency in medical device regulation, ensure that safe, effective and high-quality products are promptly brought to the market, and reduce the compliance burden on enterprises by aligning with the international standard ISO 13485:2016. The QMSR regulation will officially come into effect on February 2, 2026.
Medical device enterprises affected by QMSR regulations can systematically carry out compliance preparations through the following 7 key steps.
1. Understand the QMSR Requirements in Detail
The enterprise should read the final rules of QMSR and the full text of ISO 13485:2016 comprehensively, with a focus on understanding the new requirements and their differences from the current regulations.
2. Conduct a Gap Analysis
The enterprise should compare the existing quality management system with QMSR and ISO 13485:2016 item by item, identifying non-compliance issues and areas for improvement.
3. Develop Implementation Plans
Based on the gap analysis results, develop an implementation plan, clearly defining the schedule, responsible persons, resource allocation and training needs.
4. Train Team Members
The enterprise should provide training to employees on the relevant contents of QMSR and ISO 13485:2016 to ensure that key positions understand and fulfill their respective responsibilities.
5. Update the Quality Management System Documents
Based on the gap analysis and training feedback, revise or add the necessary QMS documents and processes.
6. Plan and Implement Internal Audits
Ensure that the implemented QMS improvement measures are effective through internal audits, and improve them further.
7. Prepare for FDA On-site Inspections
Prepare all the documents and records that meet the requirements of QMSR and ISO 13485:2016 in advance, ensuring the response capability during the FDA inspection.
The implementation of QMSR marks a significant turning point in the global medical device compliance strategy. If medical device enterprises can seize this opportunity and actively implement the above seven-step strategies, they will not only meet compliance requirements, but also gain trust and competitive advantages on the global market.
As a reliable compliance partner, closely follows global regulatory trends, Proregulations deeply analyzes the differences and connections between the FDA and ISO 13485:2016, and provides enterprises with full-process compliance support ranging from gap analysis to system reconfiguration.
Here are some of the relevant compliance services we provide:
Proregulations is dedicated to assisting medical device enterprises in effectively addressing international regulatory challenges. Whether you are in the strategic planning stage, the rectify implementation phase, or the inspection response period, we can provide you with professional, efficient, and practical solutions. If you are interested in our services, please contact us.
Related Service
U.S. Medical Device Registration with the FDA
U.S. Medical Device 510(k) Premarket Notification
U.S. FDA Medical Device Establishment Registration and Listing